MCN-03-Jun-2020 Related News
Cannabis production as extraction and distillation technologies advance
MCN explores the evolution of cannabis production as extraction and distillation technologies advance.
As the cannabis industry has blossomed and research and development in the...
A deep dive into Drug Science’s Project Twenty21
Clinical Director Dr Chloe Sakal and Project Director Amelia Middlemiss give an update on the progress of Drug Science’s groundbreakingly ambitious Project Twenty21 programme.
On...
Exploring Canada’s cannabis sector
MCN speaks with industry expert Jamie Shaw about cannabis sector regulation in Canada, the issues patients still encounter, and industry sexism.
Jamie Shaw is a...
The evolution of cannabis in the US
As the National Cannabis Industry Association celebrates its 10th anniversary, CEO Aaron Smith tells MCN about the evolution of cannabis in the US.
Aaron Smith...
Medical cannabis research and policy in Israel
Yuval Landschaft, Director of the Israeli Medical Cannabis Agency, outlines Israel’s regulatory approach to cannabis-based medical treatment.
In recent years, there has been an increase...
Cannabis research, innovation, and policy in Australia
Professor Jennifer Martin, Chair of Clinical Pharmacology at the University of Newcastle and Director of the Australia Centre for Cannabinoid Clinical and Research Excellence,...
Cannabis culture: a Latin American perspective
Writer and entrepreneur Simon Espinosa tells MCN about cannabis culture and the future of the industry in Latin America.
Trilingual writer and entrepreneur Simon Espinosa...
The Center for Medicinal Cannabis Research with Dr Igor Grant
In this article, Dr Igor Grant explores the work of the Center for Medicinal Cannabis Research.
When the Center for Medicinal Cannabis Research at UC...
“Come out firing”: Australian cannabis growth continues
With Australia’s cannabis industry growing exponentially, could legislation become more progressive?
With Australia’s cannabis economy growing exponentially following the country’s 2016 move to permit the...
What happened to cannabis stocks?
MCN examines the factors affecting the falling value of cannabis stocks and investigates whether investing in the industry is worth the risk in 2020.
Investors...
Cannabis law and policy in Gibraltar
Hassans International Law Firm Limited Partner Aaron Payas, CFA gives MCN an overview of Gibraltar’s cannabis landscape.
In October 2019, the government of Gibraltar approved...
CLEAR UK: lobbying, policy, and the flaws of CBD Novel Foods regulation
CLEAR Cannabis Law Reform President Peter Reynolds speaks to MCN about lobbying, policy and the flaws of CBD Novel Foods regulation.
CLEAR Cannabis Law Reform,...
Cannabis medicine, education, and policy in Switzerland
Professor Rudolf Brenneisen of the Swiss Society of Cannabis in Medicine tells us about medical cannabis in Switzerland.
The Swiss Society of Cannabis in Medicine...
Medical cannabis in North Macedonia
Kostadin Dukovski, President of North Macedonia’s Association of Medical Cannabis Cultivators, tells MCN about Macedonian policy, economy and future developments.
The Association of Medical Cannabis...
Education and regulation for the EU cannabis market
James O’Dowd, Secretary General of the European Alliance for Medicinal Cannabis, talks cannabis policy and oversight in the EU cannabis market.
The European Alliance for...
Medical Cannabis Network Quarterly Issue 3
Medical Cannabis Network Quarterly editor Rosemary Lobley introduces our third edition, which looks at cannabis research, policy, and national and international regulation of cannabis.
Welcome...
Discover the EUMCA with Professor Trevor Jones
Professor Trevor Jones, Chairman of the European Medicinal Cannabis Association, tells MCN Digital Editor Stephanie Price about CBD quality standards, education and evidence-based policy.
Formed...
Shaping the future of German cannabis
MCN speaks to Jürgen Neumeyer, Branchenverband Cannabiswirtschaft Managing Director, about the German cannabis landscape.
Branchenverband Cannabiswirtschaft, the German Cannabis Business Association, aims to represent all...
Novel Food Consortium to protect Europe’s hemp industry
The European Industrial Hemp Association has launched an industry consortium to share the burden of Novel Foods applications.
In the face of disparate and inconsistent...
Normal people: cannabis and policy in Norway
Ester Nafstad, Manager of Norwegian cannabis advocacy body Normal, tells MCN publication about the chapter’s goals and the need for reform of cannabis policy...
